BioLife Solutions (BLFS) earnings
In the quarter ended June 2026, BioLife Solutions had revenue of $28M, up 21.5% on a year earlier, and diluted EPS of 0.91.
On August 6, 2026 it reported EPS of 0.04 against an estimate of -0.01 (beat).
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Last | Thu Aug 6, 2026 | — | -0.01 | 0.04 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 12 quarters from BioLife Solutions's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | $28M | +21.5% | 0.91 | — | 6.0% | 2026-08-06 |
| Mar 31, 2026 | $28M | +24.7% | 0.02 | — | 0.1% | 2026-05-07 |
| Dec 31, 2025 | $19M | +24.3% | — | — | 7.2% | 2026-02-26 |
| Sep 30, 2025 | $28M | +31.2% | 0.01 | — | -0.3% | 2025-11-06 |
| Jun 30, 2025 | $23M | +18.9% | -0.33 | — | -68.8% | 2025-08-07 |
| Mar 31, 2025 | $22M | +19.6% | 0.00 | — | -2.3% | 2025-05-08 |
| Dec 31, 2024 | $15M | — | — | — | 3.6% | 2025-03-03 |
| Sep 30, 2024 | $21M | -9.3% | -0.04 | — | -2.0% | 2024-11-12 |
| Jun 30, 2024 | $20M | -32.6% | -0.45 | — | -6.6% | 2024-08-09 |
| Mar 31, 2024 | $18M | -51.1% | -0.22 | — | -17.9% | 2024-05-10 |
| Dec 31, 2023 | -$14M | — | — | — | -125.4% | 2024-02-29 |
| Sep 30, 2023 | $24M | -42.1% | -0.67 | — | -65.6% | 2023-11-09 |
Questions
How did BioLife Solutions do last quarter?
In the quarter ended June 2026, BioLife Solutions had revenue of $28M, up 21.5% on a year earlier, and diluted EPS of 0.91.
From BioLife Solutions's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.